The Hong Thai Brand Herbal Inhaler Formula 2 has been found to fail safety standards due to microbial contamination, according to an announcement published by the Food and Drug Administration (FDA). Laboratory tests conducted by the Department of Medical Sciences revealed that the product exceeded acceptable limits for Total Aerobic Microbial Count, Total Combined Yeasts and Mould Count, and Clostridium spp. contamination. The tests were carried out on samples collected from the production site of Hong Thai Commercial Herbal Products. The FDA stated that the product, registered under number G 309/62, does not comply with the Ministry of Public Health’s 2021 purity and quality standards for registered herbal products. The affected batch is number 000332, with a manufacturing date of December 9, 2024, and an expiry date of December 8, 2027. The agency has warned consumers to avoid purchasing or using the product, noting that it is considered substandard under Section 60 (2) of the Herbal Product Act B.E. 2562 (2019). Those found manufacturing such products face up to two years in prison and a fine of up to 200,000 baht, while those selling them face up to six months in prison and a fine of up to 50,000 baht. The FDA said legal proceedings against the manufacturer are under consideration. The announcement was issued on October 20, 2025. #Thailand #ยาดมหงส์ไทย